3 Month Finasteride Challenge Test Can Significantly Improve the Performance of Screening for Prostate Cancer
Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
The investigators will propose a novel method to improve prostate cancer screening with PSA,
using a 3-month treatment with finasteride, a drug used to treat Benign Prostatic Hyperplasia
(BPH) and proven to reduce a man's risk of developing prostate cancer. The investigators will
also examine three additional promising tests that may further improve diagnosis of prostate
cancer.
Phase:
Phase 4
Details
Lead Sponsor:
The University of Texas Health Science Center at San Antonio
Collaborators:
National Cancer Institute (NCI) National Institutes of Health (NIH)